Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Neoplasms 1 Nausea 1 Breast Neoplasms 1

Interventions

Dexamethasone 33 Palonosetron 27 Aprepitant 24 Ondansetron 23 Granisetron 14 Calcium Dobesilate 8 Therapeutics 7 Olanzapine 6 fosaprepitant 5 dexamethasone acetate 5 netupitant, palosentron drug combination 4 casopitant 4 Doxorubicin 4 Cyclophosphamide 4 Acupressure 4 netupitant 3 dolasetron 3 Yoga 3 Tropisetron 3 Surveys and Questionnaires 3 Radiotherapy 3 Metoclopramide 3 Dronabinol 3 Analgesia 3 ramosetron 2 ginger extract 2 dexamethasone 21-phosphate 2 Vincristine 2 Tablets 2 Psychiatric Rehabilitation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Vomiting × alizapride × Clear all

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡